Dexamethasone Efficacy in HELLP I Syndrome

Phase 3 Unknown 160 enrolled Universidad del Valle, Colombia

RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of dexamethasone for treatment of HELLP I (hemolysis, elevated liver enzymes and low platelet count) syndrome.

Timeline

Start: 2009-10
Primary completion: 2011-12
Completion: 2012-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	10 mg	Intravenous

Dexamethasone Efficacy in HELLP I Syndrome

Summary

Timeline

Drugs

Indications